GrafTech International Ltd.
Thesis
GrafTech is uniquely positioned in the ultra-high-performance electrode market due to its backward integration with needle coke production, which is critical for electrode manufacturing. The company has secured 70% of its production through locked-in contracts, ensuring predictable cash flows and margins. Given the constraints in supply and the potential for electrode prices to rise again, GrafTech presents a compelling investment opportunity.
Did it work?
No price performance data is available and the time elapsed since the pitch is unknown, so the return cannot be weighed against the long thesis. The key thesis drivers — a rise in electrode prices supported by supply constraints and the stability of the 70% contracted production base — cannot be confirmed or refuted from the information provided. Without either price evidence or verified thesis events, no definitive judgement is possible.